Chorvat; Robert John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chorvat; Robert John.The latest application filed is for "cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes".

Company Profile

0.10.3

Chorvat; Robert John - Chadds Ford PA
Chorvat; Robert John - West Chester PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers Grant 8,680,131 - McElroy , et al. March 25, 2	2014-03-25
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes Grant 7,482,470 - McElroy , et al. January 27, 2	2009-01-27
Cannabinoid Receptor Antagonists/inverse Agonists Useful For Treating Metabolic Disorders, Including Obesity And Diabetes App 20070259934 - McElroy; John Francis ; et al.	2007-11-08
Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof Grant 6,818,648 - Chorvat , et al. November 16, 2	2004-11-16
Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof App 20030191125 - Chorvat, Robert John ; et al.	2003-10-09
Arylamino fused pyridines Grant 6,448,261 - Bakthavatchalam , et al. September 10, 2	2002-09-10
Aryloxy-and arylthiosubstituted pyrimidines and triazines and derivatives thereof App 20020040026 - Chorvat, Robert John ; et al.	2002-04-04
1N-alkyl-n-arylpyrimidinamines and derivatives thereof Grant 6,342,503 - Aldrich , et al. January 29, 2	2002-01-29
6-aryloxy and arylthiopurines Grant 6,258,809 - Rajagopalan , et al. July 10, 2	2001-07-10
Azolo triazines and pyrimidines Grant 6,124,289 - He , et al. September 26, 2	2000-09-26
Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives Grant 6,124,300 - Rajagopalan , et al. September 26, 2	2000-09-26
1N-alkyl-N-arylpyrimidinamines and derivatives thereof Grant 6,107,301 - Aldrich , et al. August 22, 2	2000-08-22
Arylamino fused pyrimidines Grant 6,107,300 - Bakthavatchalam , et al. August 22, 2	2000-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.